Congress Must Honor Obama’s Global Fund Commitment “There are some encouraging signs in the epic battle against AIDS and HIV infections. … But those bright spots dim considerably in the face of the fact that about 7,100 people a day become infected. And that’s why the WHO continues to mark…
Goosby, Emanuel Address Progress, Potential Roadblocks Ahead For Introduction Of Microbicides In Developing Countries
The growing evidence supporting the promise of new HIV prevention products, like microbicides, requires that groups start planning now for how best to roll-out prevention interventions in the future, U.S. Global AIDS Coordinator Eric Goosby and Special Advisor on Health Policy to the Director of the White House Office of Management and Budget Ezekiel Emanuel said Monday during a USAID Microbicide Stakeholders Meeting in Washington.
“Drugmakers are now working on over 100 R&D projects designed to tackle diseases of the developing world and almost 80% of them are being carried out with non-industry partners,” according to a report (.pdf) released on Wednesday by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), Pharma Times reports.
Developing World Access To Medication: “Access to life-saving, essential medicines must be improved,” Josh Ruxin, founder and director of the Access Project and director of Rwanda Works,Â writes in a Forbes’ “Science Business” blog. After looking at the debate over whether the free market can help improve access and examining programs,…
Also In Global Health News: TB In Papua New Guinea; Plasmodium Vivax Malaria Vaccine; Drugs For Chagas, Leishmaniasis; Pakistan Aid Concerns; HIV Among Pregnant Women In SA
Officials Highlight TB Control Concerns In Papua New Guinea Three years intoÂ Papua New Guinea’s (PNG)Â five-year $19 million tuberculosis control plan, program funders and local health authorities are expressing concerns about its progress, IRIN reports. “In comparison with other countries … coverage of treatment in PNGÂ is lagging behind,” said Marcela Rojo,…
ASTMH Meeting Blog: The American Society of Tropical Medicine and Hygiene’s (ASTMH) “Annual Meeting Blog” has a number of posts from this week’s gathering, including: “The ethics of overseas clinical research”; an interview with John Cook, former ASTMH president; American attention to dengue fever; a profile of Michele Barry, senior…
Scientists Identify Genes That Enable Some Immune Systems To Halt HIV; Finding Could Spur Drug, Vaccine Development
“Tiny variants in a protein that alerts the body to infection could explain how one in 300 HIV-infected people are able to resist the onset of AIDS for years without needing any treatment, researchers said Thursday” in a study published online in the journal Science, Agence France-Presse reports (11/4). “The findings are encouraging for the development of vaccines because they tell scientists how the immune system might be manipulated to fend off HIV,” the Independent writes (Connor, 11/5).
Al Jazeera Examines International Trade Agreement Negotiations, Access To Generic Medicines In Low-Income Countries
Al Jazeera examines what the outcomes of two international trade agreement negotiations â€“ one regarding free trade between the EU and India and the other over anti-counterfeiting measures â€“ could mean for patients living with HIV/AIDS in low-income countries.
Sanofi Pasteur, the vaccines division of the pharmaceutical group Sanofi-Aventis, on Thursday announced the company had begun testing its dengue fever vaccine in a Phase III clinical trial in Australia, Dow Jones/Wall Street Journal reports. “Sanofi-Aventis already performed earlier clinical tests on children and adults with the vaccine in the U.S., Asia and Latin America,” Dow Jones/Wall Street Journal adds (Landauro, 11/4).
In recent years, pharmaceutical companies in the Asia-Pacific region have ramped up their clinical trial activity, patent challenges of brand name drugs and their development of new products, according to report released Tuesday by CMR International, a Thomson Reuters business, Reuters reports.